|
|
|
Insider
Information: |
Kim Lorence H. |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
1,270,945 |
|
Indirect Shares
|
168 |
|
|
Direct
Value |
$3,021,379 |
|
|
Indirect Value
|
$40,468 |
|
|
Total
Shares |
1,271,113 |
|
|
Total
Value |
$3,061,847 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
Percentage
Gain/Loss : |
-0.9%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Moderna, Inc. |
MRNA |
Chief Financial Officer |
2020-06-02 |
1,202,510 |
2018-12-11 |
0 |
Premium* |
|
Revolution Medicines, Inc. |
RVMD |
|
2023-06-08 |
65,700 |
2022-07-12 |
0 |
Premium* |
|
AmerisourceBergen Corp |
ABC |
Director |
2024-03-12 |
2,735 |
2023-03-09 |
168 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ABC |
AmerisourceBergen Corp |
Director |
|
2024-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
843 |
2,735 |
0 |
- |
|
RVMD |
Revolution Medicines, Inc... |
|
|
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,200 |
65,700 |
0 |
- |
|
ABC |
AmerisourceBergen Corp |
Director |
|
2023-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,334 |
1,892 |
0 |
- |
|
ABC |
AmerisourceBergen Corp |
Director |
|
2022-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
558 |
558 |
0 |
- |
|
ABC |
AmerisourceBergen Corp |
Director |
|
2022-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
168 |
|
% |
|
RVMD |
Revolution Medicines, Inc... |
Director |
|
2022-07-22 |
4 |
B |
$20.00 |
$1,000,000 |
D/D |
50,000 |
60,500 |
2.39 |
% |
|
RVMD |
Revolution Medicines, Inc... |
Director |
|
2022-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,500 |
10,500 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-06-02 |
4 |
AS |
$58.30 |
$14,050,300 |
D/D |
(241,000) |
1,202,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-06-02 |
4 |
OE |
$14.22 |
$4,229,087 |
D/D |
241,000 |
1,443,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-05-27 |
4 |
AS |
$51.13 |
$12,322,330 |
D/D |
(241,000) |
1,202,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-05-27 |
4 |
OE |
$12.21 |
$3,389,564 |
D/D |
241,000 |
1,443,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-05-18 |
4 |
AS |
$76.45 |
$19,791,361 |
D/D |
(241,000) |
1,202,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-05-18 |
4 |
OE |
$12.21 |
$3,000,944 |
D/D |
241,000 |
1,443,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-05-15 |
4 |
AS |
$63.80 |
$1,310,631 |
D/D |
(20,000) |
1,202,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-05-15 |
4/A |
AS |
$63.80 |
$165,880 |
D/D |
(2,600) |
1,219,910 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-05-12 |
4 |
AS |
$62.56 |
$15,541,142 |
D/D |
(241,000) |
1,222,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-05-12 |
4 |
OE |
$10.90 |
$2,642,152 |
D/D |
241,000 |
1,463,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-04-15 |
4 |
AS |
$34.24 |
$724,230 |
D/D |
(20,000) |
1,222,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-03-16 |
4 |
AS |
$24.68 |
$523,819 |
D/D |
(20,000) |
1,242,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-03-04 |
4 |
AS |
$27.71 |
$554,200 |
D/D |
(20,000) |
1,262,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-02-26 |
4 |
AS |
$27.96 |
$533,267 |
D/D |
(18,652) |
1,282,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-02-25 |
4 |
AS |
$25.59 |
$34,550 |
D/D |
(1,348) |
1,301,162 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-02-07 |
4 |
AS |
$23.06 |
$767,783 |
D/D |
(33,295) |
1,302,510 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-01-28 |
4 |
AS |
$23.37 |
$21,033 |
D/D |
(900) |
1,335,805 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Chief Financial Officer |
|
2020-01-27 |
4 |
AS |
$23.01 |
$547,753 |
D/D |
(23,805) |
1,336,705 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|